Alto Neuroscience, Inc. Common Stock (ANRO)

Total Costs & Expenses

-$44.46M

TTM · Period ending: · USD

ANRO logo

ANRO Total Costs & Expenses

Latest reported-$44.46M
ANRO TTM Total Costs & Expenses ($34.10M → -$44.46M)
High-resolution chart · PNG

ANRO total costs & expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Alto Neuroscience, Inc. Common Stock Total Costs & Expenses — Trailing twelve months (TTM) (USD)
Period endingTotal Costs & Expenses (USD)
-44,455,000
-54,902,000
-66,364,000
66,306,000
70,241,000
69,900,000
68,610,000
63,378,000
54,210,000
44,994,000
37,809,000
34,104,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.